SCHEMBL8367147

SCHEMBL8367147

COc1ccc2c(c1)c(CC(=O)O)c(C)c(=O)n2C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 8/20 0.58
AKR1C3 P42330 7/20 0.58
LMNA P02545 4/20 0.56
CYP1A2 P05177 4/20 0.56
CYP2C9 P11712 4/20 0.56
TSHR P16473 3/20 0.56
HIF1A Q16665 3/20 0.56
NPSR1 Q6W5P4 3/20 0.56
NFKB1 P19838 2/20 0.56
CYP2D6 P10635 2/20 0.56
PLA2G1B P04054 1/20 0.56
PLA2G2A P14555 1/20 0.56
PMP22 Q01453 3/20 0.54
MEN1 O00255 2/20 0.54
CYP3A4 P08684 2/20 0.54
MAPT P10636 2/20 0.54
CYP2C19 P33261 2/20 0.54
KMT2A Q03164 2/20 0.54
RGS12 O14924 1/20 0.54
ALDH1A1 P00352 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8649350 0.85 AKR1C2 (0.67) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL8366327 0.82 PTGDR2 (0.54) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL8367857 0.82 KDM4E (0.46) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL18271503 0.81 PLA2G2A (0.56) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL7907419 0.80 AKR1C2 (0.51) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL8367878 0.79 EGFR (0.45) AKR1C2AKR1C3LMNAMEN1MAPT
SCHEMBL8366206 0.76 KDM4E (0.55) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL10876035 0.75 AKR1C3 (0.76) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL18271569 0.75 AKR1C3 (0.64) AKR1C2AKR1C3LMNACYP1A2CYP2C9
SCHEMBL31224051 0.75 ALDH1A1 (0.50) NPSR1MEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5958924-A HYPOTENSIVE AGENTS, CARDIOVASCULAR DISORDERS, ANTIISCHEMIC AGENTS, RESTENOSIS, ANTICOALUGANTS, RESPIRATORY SYSTEM DISORDERS SYNTHELABO (FR) 1999-09-28 US disclosed